We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-13.22%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.1B
AUM Growth
-$3.31B
Cap. Flow
-$374M
Cap. Flow %
-2.19%
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$53M
2
ATVI
Activision Blizzard
ATVI
+$52.3M
3
TTWO icon
Take-Two Interactive
TTWO
+$47.9M
4
EBAY icon
eBay
EBAY
+$44.3M
5
CAH icon
Cardinal Health
CAH
+$35.7M

Sector Composition

Rank Sector Weight
1 Technology 21.22%
2 Healthcare 14.4%
3 Financials 10.22%
4 Consumer Discretionary 8.43%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
251
Emerson Electric
EMR
$82.9B
$15.4M 0.09%
193,538
-5,525
-3% -$487K
SCI icon
252
Service Corp International
SCI
$11.4B
$15.4M 0.09%
222,364
-9,221
-4% -$630K
WCC
253
WESCO International
WCC
$16.2B
$15.3M 0.09%
143,198
-15,058
-10% -$1.86M
WBD icon
254
Warner Bros
WBD
$64.6B
$15.2M 0.09%
1,135,907
+1,080,702
+1,958% +$20M
FBIN icon
255
Fortune Brands Innovations
FBIN
$6.12B
$15.1M 0.09%
295,173
+836
+0.3% +$49K
IRWD icon
256
Ironwood Pharmaceuticals
IRWD
$611M
$15M 0.09%
1,304,913
-141,986
-10% -$1.67M
GPK icon
257
Graphic Packaging
GPK
$3.26B
$15M 0.09%
732,749
-81,049
-10% -$1.71M
CATY icon
258
Cathay General Bancorp
CATY
$4.2B
$15M 0.09%
383,453
-40,602
-10% -$1.66M
PRGS icon
259
Progress Software
PRGS
$1.55B
$14.9M 0.09%
328,794
-34,329
-9% -$1.63M
SPSC icon
260
SPS Commerce
SPSC
$2.25B
$14.8M 0.09%
131,085
-13,111
-9% -$1.48M
MMSI icon
261
Merit Medical Systems
MMSI
$4.43B
$14.7M 0.09%
271,474
-30,733
-10% -$1.88M
DOCN icon
262
DigitalOcean
DOCN
$14.4B
$14.7M 0.09%
354,321
+182,290
+106% +$8.13M
IEMG icon
263
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$14.6M 0.09%
297,431
-90,911
-23% -$4.7M
ETN icon
264
Eaton
ETN
$157B
$14.6M 0.09%
115,696
-681
-0.6% -$95.3K
SLGN icon
265
Silgan Holdings
SLGN
$4.91B
$14.5M 0.08%
349,926
-34,184
-9% -$1.5M
SIVB
266
DELISTED
SVB Financial Group
SIVB
$14.4M 0.08%
36,374
+16,454
+83% +$7.75M
FTDR icon
267
Frontdoor
FTDR
$5.02B
$14.3M 0.08%
594,646
+139,312
+31% +$3.76M
EEM icon
268
iShares MSCI Emerging Markets ETF
EEM
$28.5B
$14.3M 0.08%
356,806
+49,437
+16% +$2.07M
EVR icon
269
Evercore
EVR
$13.1B
$14.2M 0.08%
152,033
-19,524
-11% -$2.08M
ELAN icon
270
Elanco Animal Health
ELAN
$12.4B
$14M 0.08%
713,743
-82,765
-10% -$1.96M
STAG icon
271
STAG Industrial
STAG
$7.86B
$14M 0.08%
452,530
+63,393
+16% +$2.25M
EPD icon
272
Enterprise Products Partners
EPD
$83.8B
$13.9M 0.08%
572,372
+20,422
+4% +$537K
PDM
273
Piedmont Realty Trust
PDM
$1.22B
$13.8M 0.08%
1,053,942
+96,631
+10% +$1.45M
MDLZ icon
274
Mondelez International
MDLZ
$77.7B
$13.8M 0.08%
222,196
+5,828
+3% +$368K
AZN icon
275
AstraZeneca
AZN
$263B
$13.8M 0.08%
104,182
+9,944
+11% +$1.3M

Similar funds

Glenmede Trust's Q2 2022 Portfolio in Review

As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
  • Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
  • Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
  • Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
  • Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
  • Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
  • Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.